Business
Odyssey Group International Provides Progress Update on its Life-Saving Medical Products
Odyssey Group International Provides Progress Update on its Life-Saving Medical Products.
About this update from Odyssey Health Inc.
[{"type":"text","content":"Files Quarterly Report for the Three Months Ended January 31, 2020IRVINE, CA / ACCESSWIRE / March 31, 2020 / Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to provide an update on its recent business progress.Odyssey Chairman and Chief Executive Officer Michael Redmond, commented, "With the health of our nation in focus, I am more encouraged than ever that our unique, medical products will provide clinical advantages to the market place. We are making progress on all fronts, including corporate, capital and product development. Our main goal for the remainder of 2020 is to prepare our Save a Life Choking Rescue Device and our CardioMap Device for clinical trials and regulatory submissions . We look forward to keeping our shareholders updated on our progress."Recently achieved milestones:December 2019 - began trading on the OTCQBJanuary 2020 - entered product development and design agreement for its Save a Life Choking Rescue Device with Tanaka Kapec Design GroupJanuary 2020 - entered into a development agreement with the inventor of the current CardioMap technology to design and develop the next generation deviceJanuary 2020 - Its partner company, Prevacus, completed GMP Certification on its potential concussion drug candidate and animal safety testing on its drug for Nieman Pick's type C disease.February 2020 - appointed Mike Contarino, experienced technical lead, as Head of Product Development to lead the medical device programs and oversee commercialization efforts.March 2020 - signed agreement with Majic LLC, a medical device engineering firm to assist with development and product integration of CardioMap and Save a Life Choking Rescue DeviceMarch 2020 - filed 10Q for the period ended January 31, 2020March 2020 - raised $150,000 in convertible notes with fixed floor pricing from Accredited Investors. See our 8k filings for more on the terms of the notesAbout Odyssey Group International, Inc. Odyssey Group International, Inc. (OTCQB:ODYY) is a technology and asset acquisition company with a focus in the area of life-saving medical solutions. Odyssey's corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, ...